logo
  

ImmuCell Corp. (ICCC) Has Surged To A New High After Q1 Report

ImmuCell Corp. (ICCC) reported first quarter EPS of $0.15 after the close Tuesday, compared to the loss of $0.00 in the prior year period.

ImmuCell gapped up Wednesday morning and has risen sharply in early trade on the highest volume of the year. The stock is now up 2.12 at $7.77 and has soared to a new high for the year.

For comments and feedback contact: editorial@rttnews.com

Business News

Invest in the Best Biotech Stocks by Subscribing to RTT Biotech Investor.

Jobless claims data was the highlight in this relatively light week for U.S. economics. In Europe, focus was on the U.K. economy where the Bank of England announced its latest policy decision and the first quarter GDP data were released. Find out the signals from the central bank and whether or not the UK economy exited a recession. In the Asia-Pacific, Australia's central bank delivered its latest policy verdict and China released trade figures.

View More Videos
Follow RTT